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ABSTRACT
Purpose: The purpose of this study is to psychometrically test the Evaluation of Daily Activity
Questionnaire in seven musculoskeletal conditions.
Materials and methods: One thousand and two hundred people with ankylosing spondylitis; osteoarth-
ritis; systemic lupus erythematosus; systemic sclerosis; chronic pain; chronic upper limb disorders; or
Primary Sj€ogren’s syndrome completed the Evaluation of Daily Activity Questionnaire, Health Assessment
Questionnaire and Short-Form Health Survey v2. We examined internal construct validity using Rasch ana-
lysis, internal consistency, concurrent validity with the Health Assessment Questionnaire and Short-Form
Health Survey v2. Participants repeated the Evaluation of Daily Activity Questionnaire to assess test–retest
reliability.
Results: The 12 domains satisfied Rasch model expectations for fit, local dependency, unidimensionality
and invariance by age and gender, in each musculoskeletal condition. Internal consistency was consistent
with individual use (Cronbach’s a> 0.90); concurrent validity was strong (Health Assessment
Questionnaire: rs¼ 0.60–0.92; Short-Form Health Survey v2 Physical Function: rs¼0.61 to 0.91) and tes-
t–retest reliability excellent (Intra-Class Correlation Coefficient(2,1)¼ 0.77–0.96).
Conclusion: The Evaluation of Daily Activity Questionnaire satisfied Rasch model requirements for con-
struct validity and has good reliability and validity in each MSC. The Evaluation of Daily Activity
Questionnaire can be used as a measure of everyday activity in practice and research with people with
musculoskeletal conditions.
 IMPLICATIONS FOR REHABILITATION
 The Evaluation of Daily Activity Questionnaire evaluates users’ ability to perform common daily activ-
ities (in 12 domains) that were identified as problematic by people with seven musculoskeletal condi-
tions (i.e., osteoarthritis, systemic lupus, ankylosing spondylitis, chronic pain, chronic upper limb
conditions, systemic sclerosis, Sjogren’s syndrome).
 Most patients considered the Evaluation of Daily Activity Questionnaire was the right length and
would be helpful for discussing everyday problems with an occupational therapist.
 The 12 domains have good reliability and validity and can be combined into two components: Self-
Care and Mobility.
 The Evaluation of Daily Activity Questionnaire is suitable for use both in clinical practice and research
and a User Manual is available for therapists and researchers.
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Introduction
A fifth of adults have long-term musculoskeletal conditions; a
third of whom experience activity limitations [1]. In the UK, over 3
million adults with musculoskeletal conditions are disabled by
pain, fatigue, reduced hand function, and/or mobility restrictions
[2]. Thorough assessment is needed to effectively identify activity
abilities and participation but few rheumatology occupational
therapists in the United Kingdom (UK) use standardised measure-
ment tools during their assessments. This is because measurement
tools commonly used in rheumatology out-patient clinics and
research (e.g., the Health Assessment Questionnaire [3] and the
Arthritis Impact Measurement Scales 2 [4]) include too few activ-
ities to be of use for treatment planning. Many occupational ther-
apy departments have, therefore, devised their own non-
standardised checklists, with differing activities and rating scales
[5,6]. Unfortunately, such checklists cannot be used for research
and audit, or within clinical practice to evaluate changes in clients’
abilities, as they lack validity and reliability.
The Evaluation of Daily Activity Questionnaire was developed
in the early 1990s in Sweden to address these problems. It is a
patient-reported outcome measure evaluating common symptoms
and measuring, in depth, activity limitations in rheumatoid
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arthritis [7,8]. Patients normally complete it at home, allowing
them time to reflect on their abilities and activity limitations. It
normally takes between 25 and 35min to complete [6]. During
appointments, therapists can then quickly focus on the problems
identified, reducing the need for detailed interviews. We have
already developed an English Evaluation of Daily Activity
Questionnaire, which has recently been linguistically and culturally
validated for use in the UK (from the original Swedish version)
[9,10] and shown to be psychometrically robust for use with
patients with rheumatoid arthritis [11]. Each of the 12 Evaluation
of Daily Activity Questionnaire domains is unidimensional and
these domains cluster into two components: Self-Care and
Mobility (see Table 1; and Supplementary Document S2).
The Evaluation of Daily Activity Questionnaire has also been
used in other musculoskeletal conditions in Sweden [12–14] but
has not been psychometrically tested. Thus, the aim of this paper
is to assess the psychometric properties of the Evaluation of Daily
Activity Questionnaire with other musculoskeletal conditions to
assess its suitability for use in clinical practice and research. As a
first step we demonstrated content validity of the Evaluation of
Daily Activity Questionnaire to ensure it reflects the symptoms,
condition impact and activity limitations experienced by people
with other musculoskeletal conditions, as these could differ from
rheumatoid arthritis [15]. The musculoskeletal conditions were
ankylosing spondylitis; osteoarthritis; systemic lupus erythemato-
sus; systemic sclerosis [scleroderma]; chronic (i.e., >3months) pain
(i.e., fibromyalgia; widespread, back or neck pain); chronic hand/
upper limb disorders; and Primary Sj€ogren’s Syndrome [15]. The
conditions included are those most frequently referred to
Rheumatology occupational therapists. While other musculoskel-
etal conditions are prevalent, these are either less often referred
to occupational therapy (e.g., polymyositis) or have similar impacts
on daily activities as rheumatoid arthritis (e.g., psoriatic arthritis).
During the study, although a condition infrequently referred to
occupational therapy, the opportunity arose to include people
with Primary Sj€ogren’s Syndrome. We now report the internal
construct validity; internal consistency; concurrent validity and
test–retest reliability.
Materials and methods
Participants and data collection
Ethical approval was obtained from the Greater Manchester West
Research Ethics Committee (11/H1014/5) and the University of
Salford Research Ethics Panel. To ensure as representative as sam-
ple as possible we used a range of recruitment strategies: from
National Health Service (NHS) out-patient departments (19
Rheumatology, three Orthopaedic/Hand clinics); four General
Practices; the UK Primary Sj€ogren’s Syndrome Registry; and ran-
domly selected members of 10 patient organisations: the National
Ankylosing Spondylitis Society; Lupus UK; Raynaud’s and
Scleroderma Society; Scleroderma Society; Back Care; Fibroaction;
the Fibromyalgia Association; the British Sj€ogren’s Syndrome
Association; RSI Action (a repetitive strain injury organisation); and
a private physiotherapy practice linked with RSI Action.
Potential participants were invited to participate by research
nurses or occupational therapists in the NHS sites, and by staff in
the patient organisations, in person, by mail or via the organ-
isations’ websites. Those recruited via patient organisations com-
pleted telephone screening and consent procedures with a
member of the research team (Y. P.).
Participants meeting the following criteria were eligible: a con-
firmed diagnosis of one of the seven musculoskeletal conditions;
ability to read, write and understand English; no change in any
disease-modifying medication (which could affect test-retest reli-
ability) in the last three months (and not about to); and no other
medical condition(s) limiting their activities of daily living. Other
medical conditions associated with that musculoskeletal condition
were acceptable, e.g., people with systemic lupus erythematosus
could also have secondary osteoarthritis, fibromyalgia or internal
organ involvement.
After providing informed written consent, participants were
given or mailed a questionnaire booklet to complete at home and
return by mail. The booklet included: questions to describe the
recruited population: age, gender, marital, educational and
employment status, disease duration and medication regimen, as
well as the measures described below. Two to three weeks later,
participants were mailed the Evaluation of Daily Activity
Questionnaire to complete at home a second time (to evaluate
test–retest reliability). Two reminders were sent if necessary.
Measurement instruments
The English Evaluation of Daily Activity Questionnaire includes two
parts: Part 1 comprises 10 numerical rating scales, scored on a 0
(no) to 10 (severe) scale, to assess symptom severity, mood and
life satisfaction. Part 2 comprises 120 activities in 12 domains,
scored on a 3-point (0¼no difficulty, 3¼ unable to do) scale
which assesses ability to perform daily activities. If the person
would not normally perform that activity, there is a “not
applicable” option. For example, if they had never learnt to drive
then “drive a car, e.g., holding a steering wheel, turning car keys
or changing gear” would be “not applicable”. Each item is
answered twice on the same page by rating performance without
(Section A) and then with (Section B) ergonomic solutions (e.g.,
alternative methods, assistive devices, environmental modifica-
tions). Items are summed to produce total scores for Sections A
and B within each domain, with any score reductions between
Sections A and B denoting the impact of ergonomic solutions on
improving activity ability. If there are missing items within a
domain, a total domain score cannot be calculated. Higher scores
indicate greater activity limitations [8,10,11]. The EDAQ and EDAQ
Manual are available for download [9,10].
The comparator health measures selected are those widely
used in Rheumatology, validated in a range of musculoskeletal
conditions and pragmatic choice as the same questionnaire was
used across all conditions [16].
The Medical Outcomes Survey 36 item Short-Form Health Survey
version 2 (known as the SF36v2) includes 36 items from which sub-
scales of Physical Function, Bodily Pain, Vitality and Mental Health
can be calculated using Quality Metric Health OutcomesTM Scoring
Software 4.5 [17–20]. Lower scores denote worse health states.
The Health Assessment Questionnaire includes ability to per-
form 20 daily activities rated on a 0–3 scale (0¼not at all
difficult, 3¼ unable to do) [3] using the Health Assessment
Table 1. Domains within the self-care and mobility components of the evalu-
ation of daily activity questionnaire.
Components: domain numbers and names
Self-care Mobility
1 Eating/drinking 4 Bathing/showering
2 Personal care 6 Moving around indoors
3 Getting dressed/undressed 9 Moving and transfers
5 Cooking 11 Moving around outside/shopping
7 Cleaning the house 12 Gardening/household maintenance
8 Laundry/clothes care
10 Communication
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Questionnaire 20 method, in which the total score is obtained
by summing all 20 items (0–20¼mild; 21¼ 40¼moderate;
and 41–60¼ severe disability). This method was used as the
Health Assessment Questionnaire 20 does not weight items worse
if an assistive device is used, as occurs when normally scoring the
Health Assessment Questionnaire [21,22]. Higher scores denote
greater activity limitations.
Hand pain was measured using a numeric rating scale of pain
in the hand and wrists during moderate activities (e.g., cooking a
meal, doing housework, doing light gardening) in the past week
on a 0 (no) to 10 (severe) scale.
The Quality of Life Scale measures satisfaction with participation
(e.g., work, relationships, health) in 16 items on a 7-point scale
(1¼ terrible to 7¼delighted) [23]. Lower scores denote worse
quality of life.
Perceived health status was measured using a 5-point numeric
rating scale asking “Considering all the ways that your condition
affects you, how have you been over the past month?” (1¼ very
good: no symptoms and no limitations to normal daily activities
to 5 very poor: very severe symptoms and inability to carry out
most activities).
Perceived change in health status: At Test 2 only, this was meas-
ured using a 5-point numeric rating scale by asking “Overall, how
much is your arthritis troubling you now compared to when you
last completed this questionnaire a few weeks ago?”: (1¼much
less; 2¼ somewhat less; 3¼ about the same; 4¼ somewhat more;
5¼much more).
Acceptability of the Evaluation of Daily Activity Questionnaire:
Closed questions were included to identify participants’ views
about whether the Evaluation of Daily Activity Questionnaire
would be helpful in discussions with occupational therapists (not
at all, a little, moderately, very); and the number of activities
included in the Evaluation of Daily Activity Questionnaire (too
many, about right, too few).
Sample size
As Rasch analysis was used to assess the construct validity of the
Evaluation of Daily Activity Questionnaire Part 2, a sample size of
at least 150 in each musculoskeletal condition was recruited. This
number was determined from the need to ensure that a uniform
distribution of patients was obtained across the construct of activ-
ity limitation, so that the precision of the estimate of both persons
and items, across the construct, remains similar and a sufficient
number of cases were collected within each musculoskeletal con-
dition group to test for invariance across groups [24]. The sample
does not need to be representative of the selected population, as
the mathematical model is independent of distribution, but it
should have a good distribution across the activity limitation
domain, as well as sufficient cases within each diagnostic group
[24]. At least, 79 sets of repeated responses were required in each
musculoskeletal condition to demonstrate that a test–retest correl-
ation of 0.7 differs from a background correlation (constant) of
0.45, with 90% power at the 1% significance level. A test re-test
correlation of 0.7 is deemed a minimum acceptable level [25].
Statistical analyses
For Part 2 Evaluation of Daily Activity Questionnaire domains, total
scores for each domain were summed from the raw scores for
Sections A and B. Domain scores were summed to form the two
component (Self-Care and Mobility) scores (see Table 1). Non-para-
metric statistics were used for classical psychometric testing as
scores are ordinal.
Internal construct validity of the Evaluation of Daily Activity
Questionnaire was tested through fit of data to the Rasch meas-
urement model [26]. This process of Rasch analysis involves a ser-
ies of tests of various assumptions such as stochastic ordering,
local independence and unidimensionality [27]. Following an itera-
tive process, the scale is assessed and, (if necessary) revised. The
process is described in detail elsewhere [28,29]. Briefly, the sto-
chastic ordering is assessed through fit statistics. Given perfect fit
to the Rasch model, the (z-standardised) item and person residuals
would have a mean value of 0 and a SD of 1. If the SD >1.4 then,
broadly speaking, this is an indicator that there may be issues at
the individual item level. If the mean value is positive, then this
indicates that, on an average, the items are under-discriminating,
and if the mean value is negative, then this indicates that, on an
average, the items are over-discriminating. The Chi-square p val-
ues for each item (domain) should be non-significant (Bonferroni
adjusted), indicating no deviation from model expectations.
Unidimensionality is tested in a post-hoc procedure introduced by
Smith [30]. Two independent sets of items were selected to derive
two separate estimates of the trait for each individual. Under the
assumption of unidimensionality, no difference in these estimates
is expected. This was tested by a series of t-tests (one for each
individual) [30], and the proportion of significant t-tests should
be<5% to indicate unidimensionality. The property of invariance
across groups (Differential Item Functioning), is tested for by age,
gender and condition groups [24,26,27,31]. Ideal Fit and other
indicators are shown at the bottom of the fit table. The unre-
stricted partial-credit model was used [32] using RUMM 2030 soft-
ware [33].
In the current study, the Rasch analysis was used to test the 12
domain, two component model of the Evaluation of Daily Activity
Questionnaire Part 2 (developed in our previous study in rheuma-
toid arthritis [11]) in each of the seven musculoskeletal conditions.
(As the domain level approach was utilized in the RA validation,
this same approach was retained for practicality and consistency).
That is, the items within each domain (e.g., Eating) were sum-
mated into a domain score which was then entered into the ana-
lysis as 12 “super items” or testlets [34]. These were also
subsequently grouped into the two components of Self Care and
Mobility. If data are found to satisfy Rasch model assumptions,
data can be transformed from an ordinal to an interval scale using
Rasch transformation tables, if required [35,36]. Normally, summed
(ordinal) total scores are calculated for Evaluation of Daily Activity
Questionnaire domains. However, Rasch transformation to an
interval scale allows for reliability testing using intra-class correl-
ation coefficients (ICC(2,1)) and calculation of sensitivity to change
statistics.
Internal consistency was tested using the Person Separation
Index, obtained in the Rasch analysis, and Cronbach’s alpha.
Results of 0.8 are seen as good to excellent [37]. Both should be
interpreted in the same way, with a value 0.85 consistent
with individual-level use, and a value>0.7 consistent with group-
level use.
Concurrent validity was tested in each musculoskeletal condi-
tion using Spearman’s correlations by comparing the numeric rat-
ing scale scores in the Evaluation of Daily Activity Questionnaire
Part 1 for pain, fatigue and mood with the SF36v2 Bodily Pain,
Vitality (fatigue) and Mental Health scales, and the scores for each
Part 2 domain were compared with: the Health Assessment
Questionnaire 20; SF-36v2; hand pain numeric rating scale; Quality
of Life Scale; and differing perceived health status question (as
detailed above). Correlations are interpreted as: very strong
(0.8–1.00); strong (0.6–0.79); moderate (0.4–0.59); weak (0.20–0.39);
and very weak (0.00–0.19) [37]. We hypothesised that there would
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be strong positive correlations between Evaluation of Daily
Activity Questionnaire domain scores and Health Assessment
Questionnaire 20 scores and strong negative correlations with the
SF36v2 Physical Function scale, as these measures also assess
activity limitations. We hypothesised that there would be moder-
ate negative correlations with SF36v2 Bodily Pain, SF36v2 Vitality
and Quality of Life scale measures, and moderate positive correla-
tions with hand pain and perceived health as these factors are
known to influence or are influenced by activity limitations.
Discriminant validity was tested using Kruskal–Wallis tests to
evaluate differences in Part 2 domain scores for each musculoskel-
etal condition in the different perceived health status groups.
Test–retest reliability was assessed for those stating they
were “about the same” at Test 2, using linear weighted kappa
for numeric rating scales of Part 1 and each activity in Part 2 [38].
Levels of agreement are interpreted as <0.20¼poor;
0.21–0.40¼ fair; 0.41–0.60¼moderate; 0.61–0.80¼ good; 0.81–1.00
¼ very good [39]. Intra-class correlation coefficients (ICC(2,1: two-
way random, consistency, average measures model in SPSS) for
Rasch transformed Evaluation of Daily Activity Questionnaire
domain scores (see below) were also calculated with a 95% confi-
dence interval. An intra-class correlation coefficient 0.75 was
considered to be excellent [40].
Sensitivity to change was assessed with the Standard Error of
Measurement and the Minimal Detectable Change95 score (i.e. a
statistical estimate of the smallest detectable change correspond-
ing to change in ability) [41,42]. These cannot be calculated from
Evaluation of Daily Activity Questionnaire domain scores which
are summed from ordinal data [43]. Accordingly, Rasch trans-
formed scores for the 12 Evaluation of Daily Activity Questionnaire
domains, conditional upon fit to the model, for each condition,
were first created [10]. Raw scores for each Evaluation of Daily
Activity Questionnaire domain were first transformed to the metric
(in logits) then linearly transformed to produce an interval-level
scale of the same range for each domain for each condition.
Rasch transformed scores were then used to calculate the
Standard Error of Measurement and the Minimal Detectable
Change95.
Floor and ceiling effects were considered present if >15% of
participants achieved either the lowest (floor, i.e., at, or close to,
zero) or highest (ceiling, i.e., at, or close to, the maximum) scores
in any domain [44,45]. For the EDAQ, lower scores represent fewer
difficulties, and higher scores represent more difficulties.
Acceptability was assessed by calculating the percentages of
optional responses for the number of activities in the Evaluation
of Daily Activity Questionnaire and its helpfulness in discussing
daily activity problems with an occupational therapist.
The Statistical Package for Social Science v20 [46] was used for
validity and reliability analyses and MedCalc [47] for linear
weighted kappa for Part 1 numeric rating scales and Part 2 indi-
vidual item reliability testing.
Results
Participants
Overall, 1231 NHS patients were screened, of whom 908 (74%)
were eligible and willing to take part. About 3365 letters were
mailed via patient organisation and 615 (18%) members
responded. Of these 1523 people, 1414 (93%) consented and
1205 (85%) returned the Test 1 questionnaires. Participants
recruited from the NHS or patient organisations within each mus-
culoskeletal condition were not significantly different in age, gen-
der or condition duration. However, groups were different for
educational level in ankylosing spondylitis, chronic pain and
chronic hand/upper limb disorders, with patient organisation
members having higher educational attainment (data not shown).
Five were withdrawn from the Chronic Upper Limb Disorders
group as they did not have eligible conditions, meaning 1200
(84.5%) participated: 691 (58%) from the NHS and 509 (42%)
from patient organisations. Test 2 was returned by 943 (79%)
participants. Median time between Test 1 and Test 2 was 49
(inter-quartile range 42–64) days. Participant descriptors are
detailed in Table 2.
Internal construct validity
Rasch analyses of the seven domains of the Self-Care Component
indicated good fit to the model within each musculoskeletal con-
dition (Table 3), items (domains) were free from Differential Item
Functioning apart from Differential Item Functioning -by-gender in
Cooking (Chronic Upper Limb Conditions) and Cleaning the House
(Ankylosing Spondylitis). For the five domains of the Mobility com-
ponent (Table 4), the overall fit statistics were also good within
each musculoskeletal condition. Items (domains) within all muscu-
loskeletal conditions were free from Differential Item Functioning,
apart from Differential Item Functioning-by-gender in Moving and
Transfers (Osteoarthritis). Both components were shown to be uni-
dimensional with the exception of Chronic Pain in Self Care.
Further detailed Rasch analysis of the items sets within each
domain (i.e., summating to the domain level) can be found in the
Supplementary Tables S1–S7.
Additionally, all conditions were pooled to assess Differential
Item Functioning by condition. If Evaluation of Daily Activity
Questionnaire domain-items work in the same way across condi-
tions, Evaluation of Daily Activity Questionnaire scores could be
directly compared between them. A random, similarly sized sam-
ple of data from the previous rheumatoid arthritis study [11] was
also included in this analysis. In the Self-Care component, only
Personal Care and Laundry/Clothes Care were free from
Differential Item Functioning. In the Mobility component, only
Moving around Outdoors/Shopping was free from Differential
Item Functioning. Consequently, post-hoc Tukey tests were con-
ducted to determine which domains were different across condi-
tions, with pairwise tests for each between-condition comparison.
Following DIF identification, domain-item splitting then accounted
for any cross-conditional Differential Item Functioning present and
the analysis calibration remains linked by the common items.
Differential Item Functioning-splitting was done on an iterative
basis, with the item displaying the largest Differential Item
Functioning resolved first. This analysis identified a calibrated
common metric for each of the Self-Care and Mobility compo-
nents, where all cross-conditional Differential Item Functioning
has been accounted for. Supplementary Tables 10 and 11 show
the breakdown of where Differential Item Functioning splitting
was necessary to obtain an unbiased calibration. As a result, Rasch
transformation tables were also developed to allow comparison of
Evaluation of Daily Activity Questionnaire domain scores between
conditions [10].
Internal consistency
In all musculoskeletal conditions, internal consistency (Person
Separation Index) for the Self-Care and Mobility components was
consistent with group-level use (i.e., >0.7) (Tables 3 and 4) and
Cronbach’s alpha was good to excellent (i.e., 0.85, consistent
with individual level use) in almost all 12 Evaluation of Daily
Activity Questionnaire domains (apart from Communication in
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systemic sclerosis ((a¼ 0.83), indicating the components and indi-
vidual domains could be used individually as well as collectively
(Table 5).
Concurrent validity
In Part 1, there were moderate to very strong correlations
between comparable numeric rating scales from Part 1 and
SF36v2 Mental Health, Vitality and Bodily Pain scales (rs¼0.53 to
0.84; Supplementary Table S8). In Part 2, most (i.e., 75% or
more) Evaluation of Daily Activity Questionnaire domains
correlated:
 very strongly/strongly with Health Assessment
Questionnaire20 (rs: 0.60 to 0.92) and SF36v2 Physical
Function (rs: 0.61 to 0.91) (Table 5);
 moderately/strongly with SF36v2 Bodily Pain (rs: 0.40 to
0.75), Hand Pain (rs: 0.40–0.67) (Table 5) and Perceived
Health status (rs:0.40–0.75) (Supplementary Table S9);
 moderately with SF36v2 Vitality (rs:0.40 to 0.59) and
the Quality of Life Scale (rs:0.40 to 0.56)
(Supplementary Table S9).
Discriminant validity
Parts 1 and 2 showed very good discriminant validity. In all seven
musculoskeletal conditions, all the Part 1 numeric rating scales
and each Part 2 domain showed significant differences (p< 0.001)
between those who perceived their health status to be good/very
good; fair; or poor/very poor (data not shown).
Test–retest reliability
Test–retest reliability for Part 1 was moderate to good
(Supplementary Table S8) and for Rasch transformed data for Part
2 domains were excellent (ICC(2,1 0.9 for most tests) (Table 5).
Linear weighted kappa scores for individual items in Part 2
showed moderate to very good test-retest reliability across most
domains for most conditions (data not shown).
Sensitivity to change
Most Minimal Detectable Change95 scores ranged from 0.27 to
6.00, although some were higher (Supplementary Table S9).
Floor and ceiling effects
All Part 2 domains across most conditions demonstrated some
floor effects, with the highest floor effects observed in the anky-
losing spondylitis and Primary Sj€ogrens Syndrome groups in the
following domains: Eating, Personal Care, Cooking, Laundry and
Communication. No ceiling effects were seen in the domains.
Acceptability
There was a slightly lower response rate for the Acceptability
questions. Most (986/1120: 88%) considered that the Evaluation of
Daily Activity Questionnaire included about the right amount of
activities, or could have been longer; and most (869/1147:76%)
considered it would be helpful or very helpful for discussing
everyday problems with an occupational therapist.
Discussion
The Evaluation of Daily Activity Questionnaire is a robustly con-
structed, acceptable, valid, reliable measure of daily activity in
these seven musculoskeletal conditions, as well as in rheumatoid
arthritis [11]. It includes the commonest activity limitations people
with these conditions experience. It thus meets the needs of occu-
pational therapists and physiotherapists for a comprehensive
patient reported outcome measure of activity ability for use across
Table 4. Rasch analysis summary for the mobility component for each musculoskeletal condition.
Item residual Person residual Chi-square interaction Unidimensionality
Analysis Mean SD Mean SD SD Value DF p PSI % t-test CI
AS 0.16 0.52 0.53 0.95 6.89 10 0.74 0.86 4.07 a
OA 0.25 1.24 0.49 0.9 5.89 10 0.82 0.83 5.08 0.00%
SLE 0.46 0.88 0.43 0.75 8.48 10 0.58 0.82 1.49 a
SS 0.19 0.91 0.44 0.87 13.47 10 0.20 0.79 5.08 0%
CP 0.69 1.29 0.71 1.03 4.36 10 0.93 0.85 8.05 3.50%
CULD 0.2 1.02 0.35 0.75 12.93 10 0.23 0.71 4.62 a
PSS 0.29 0.82 0.53 0.95 7.54 10 0.67 0.72 6.25 0.00%
Fit criteria 0.0< 1.4a 0.0< 1.4 > 0.05 >0.85 Lower CI <5%
AS: ankylosing spondylitis; OA: osteoarthritis; SLE: systemic lupus erythematosus; SS: systemic sclerosis; CP: chronic pain conditions; CULD: chronic hand/upper limb
disorders; PSS: Primary Sj€ogren’s syndrome.
aBonferroni adjusted.
Table 3. Rasch analysis summary for the self-care component for each musculoskeletal condition.
Item residual Person residual Chi-square interaction Unidimensionality
Analysis Mean SD Mean SD Value DF p PSI % t-test CI
AS 0.34 1.09 0.4 0.8 20.82 14 0.12 0.74 3.45 a
OA 0.16 1.55 0.43 1.03 20.1 14 0.12 0.82 5.77 2.30%
SLE 0.3 0.84 0.39 0.87 13.83 14 0.46 0.85 6.11 2.40%
SS 0.29 0.84 0.41 0.93 10.23 14 0.75 0.85 3.55 a
CP 0.02 1 0.45 1.17 14.06 14 0.45 0.89 9.88 6.50%
CULD 0.45 1.6 0.44 0.88 16.06 14 0.31 0.77 4.20 a
PSS 0.54 1.02 0.46 0.85 20.65 14 0.11 0.75 1.69 a
Fit Criteria 0.0< 1.4a 0.0< 1.4 > 0.05 >0.85 Lower CI <5%
SD: standard deviation; DF: degrees of freedom; PSI: Person Separation Index CI: confidence interval; AS: ankylosing spondylitis; OA: osteoarthritis; SLE: systemic lupus
erythematosus; SS: systemic sclerosis; CP: chronic pain conditions; CULD: chronic hand/upper limb disorders; PSS: Primary Sj€ogren’s syndrome.
aBonferroni adjusted.
6 A. HAMMOND ET AL.
Ta
bl
e
5.
Re
lia
bi
lit
y
an
d
va
lid
ity
te
st
in
g
of
th
e
ED
AQ
Pa
rt
2
fo
r
ea
ch
m
us
cu
lo
sk
el
et
al
co
nd
iti
on
(n
¼
12
00
).
Ev
al
ua
tio
n
of
D
ai
ly
Ac
tiv
ity
Q
ue
st
io
nn
ai
re
do
m
ai
n
(s
co
re
ra
ng
e)
n
Te
st
1
A
Cr
on
ba
ch
’s
a
M
ed
ia
n
(r
an
ge
)
Te
st
1
sc
or
e
M
ed
ia
n
(r
an
ge
)
Te
st
2
sc
or
e
IC
C(
2,
1)
Co
rr
el
at
io
n
w
ith
H
ea
lth
As
se
ss
m
en
t
Q
ue
st
io
n-
na
ire
20
(r
s)
Co
rr
el
at
io
n
w
ith
SF
36
v2
:P
hy
si
ca
l
Fu
nc
tio
n
(r
s)
Co
rr
el
at
io
n
w
ith
SF
36
v2
:B
od
ily
Pa
in
(r
s)
Co
rr
el
at
io
n
w
ith
H
an
d
Pa
in
(r
s)
1.
Ea
tin
g
&
dr
in
ki
ng
(0
–3
3)
AS
16
1
0.
93
0
(0
–3
)
0
(0
–3
)
0.
85
(0
.7
9,
0.
90
)
0.
52
a
0
.5
6a
0
.4
2a
0.
55
a
O
A
17
5
0.
93
5
(1
–9
)
4
(0
.7
5–
8)
0.
94
(0
.9
2,
0.
96
)
0.
50
a
0
.1
9b
0
.4
0a
0.
58
a
SL
E
15
5
0.
94
4
(1
–8
)
3.
5
(1
–7
)
0.
90
(0
.8
6,
0.
93
)
0.
81
a
0
.6
8a
0
.6
2a
0.
64
a
SS
16
1
0.
91
7
(4
–1
2)
6
(3
–1
2)
0.
91
(0
.8
8,
0.
94
)
0.
72
a
0
.5
4a
0
.5
0a
0.
55
a
CP
18
5
0.
94
5
(1
–1
0)
5
(1
–1
0)
0.
92
(0
.8
9,
0.
95
)
0.
75
a
0
.5
6a
0
.5
3a
0.
56
a
CU
LD
14
5
0.
94
4(
1–
9)
4
(0
.2
5–
9)
0.
89
(0
.8
4,
0.
93
)
0.
72
a
0
.5
0a
0
.5
5a
0.
66
a
PS
S
15
8
0.
93
3
(0
–7
)
3.
5
(0
–7
)
0.
94
(0
.9
2,
0.
96
)
0.
72
a
0
.6
1a
0
.5
6a
0.
61
a
2.
Pe
rs
on
al
ca
re
(0
–3
6)
AS
15
5
0.
91
0
(0
–2
)
0.
5
(0
–2
)
0.
92
(0
.8
8,
0.
94
)
0.
76
a
0
.6
9a
0
.5
9a
0.
44
a
O
A
16
3
0.
89
2
(1
–4
)
1
(0
–3
)
0.
86
(0
.8
1,
0.
90
)
0.
70
a
0
.4
2a
0
.4
4a
0.
47
a
SL
E
15
4
0.
92
1
(0
–3
)
1
(0
–3
)
0.
92
(0
.8
8,
0.
94
)
0.
84
a
0
.7
2a
0
.6
3a
0.
56
a
SS
16
0
0.
85
2
(1
–5
)
2
(0
–5
)
0.
81
(0
.7
3,
0.
86
)
0.
72
a
0
.5
4a
0
.4
6a
0.
46
a
CP
18
5
0.
90
3
(0
–6
)
2
(0
–6
)
0.
94
(0
.9
2,
0.
96
)
0.
84
a
0
.6
6a
0
.5
4a
0.
37
a
CU
LD
14
6
0.
91
1
(0
–4
.2
5)
1
(0
–5
)
0.
92
(0
.8
8,
0.
95
)
0.
76
a
0
.5
1a
0
.5
9a
0.
53
a
PS
S
16
0
0.
86
0
(0
–2
)
1
(0
–3
)
0.
94
(0
.9
2,
0.
96
)
0.
71
a
0
.5
6a
0
.4
9a
0.
54
a
3.
D
re
ss
in
g
(0
–3
3)
AS
16
0
0.
91
3
(0
–7
)
3
(0
–6
)
0.
91
(0
.8
7,
0.
94
)
0.
80
a
0
.7
6a
0
.6
3a
0.
48
a
O
A
17
4
0.
92
4
(2
–8
)
4
(1
.2
5–
7)
0.
83
(0
.7
6,
0.
88
)
0.
76
a
0
.5
6a
0
.5
0a
0.
40
a
SL
E
16
0
0.
94
2
(0
–8
)
1.
5
(0
–6
.7
5)
0.
92
(0
.8
8,
0.
94
)
0.
83
a
0
.7
9a
0
.6
2a
0.
57
a
SS
16
6
0.
92
4
(2
–1
1)
4
(1
–1
1)
0.
94
(0
.9
1,
0.
95
)
0.
81
a
0
.6
4a
0
.4
1a
0.
43
a
CP
18
4
0.
93
6
(3
–1
1)
5
(2
–1
1
0.
91
(0
.8
8,
0.
94
)
0.
86
a
0
.7
0a
0
.6
0a
0.
52
a
CU
LD
14
8
0.
94
3
(0
–7
)
2
(0
–6
.7
5)
0.
93
(0
.8
9,
0.
95
)
0.
82
a
0
.6
1a
0
.5
7a
0.
46
a
PS
S
16
0
0.
91
1
(0
–5
)
1
(0
–5
)
0.
92
(0
.8
8,
0.
96
)
0.
79
a
0
.6
8a
0
.6
1a
0.
54
a
4.
Ba
th
in
g
an
d
sh
ow
er
in
g
(0
–3
3)
AS
15
6
0.
89
3
(0
–7
)
2.
5
(0
–6
)
0.
93
(0
.8
9,
0.
94
)
0.
84
a
0
.7
7a
0
.6
0a
0.
42
a
O
A
17
4
0.
92
4
(2
–9
)
3
(1
–6
)
0.
92
(0
.8
9,
0.
95
)
0.
82
a
0
.6
8a
0
.5
9a
0.
43
a
SL
E
15
3
0.
94
2
(0
–8
)
2
(0
–8
)
0.
94
(0
.9
2,
0.
96
)
0.
87
a
0
.7
9a
0
.6
9a
0.
61
a
SS
16
0
0.
91
4
(0
.2
5–
9)
4
(0
–1
0)
0.
93
(0
.9
0,
0.
95
)
0.
87
a
0
.7
9a
0
.4
2a
0.
45
a
CP
17
8
0.
93
7.
5
(3
–1
2)
6
(2
–1
2)
0.
92
(0
.8
8,
0.
94
)
0.
87
a
0
.7
6a
0
.6
3a
0.
47
a
CU
LD
14
8
0.
92
3
(1
–7
)
3
(0
–7
)
0.
91
(0
.8
7,
0.
94
)
0.
88
a
0
.6
5a
0
.6
7a
0.
52
a
PS
S
16
2
0.
92
1
(0
–6
)
1
(0
–5
)
0.
96
(0
.9
4,
0.
97
)
0.
80
a
0
.7
5a
0
.6
5a
0.
51
a
5.
Co
ok
in
g
(0
–4
2)
AS
15
8
0.
96
1
(0
–6
.5
)
1
(0
–4
.5
)
0.
88
(0
.8
3,
0.
92
)
0.
79
a
0
.7
7a
0
.6
1a
0.
54
a
O
A
17
4
0.
95
5
(1
–1
1)
4
(1
–1
0)
0.
94
(0
.9
1,
0.
96
)
0.
75
a
0
.4
6a
0
.5
4a
0.
53
a
SL
E
15
7
0.
96
5
(1
–1
4)
4
(0
–1
2.
5)
0.
96
(0
.9
4,
0.
97
)
0.
87
a
0
.7
8a
0
.6
5a
0.
63
a
SS
16
3
0.
95
6
(1
–1
2)
5
(1
–1
2)
0.
93
(0
.9
0,
0.
95
)
0.
86
a
0
.7
6a
0
.5
2a
0.
56
a
CP
17
7
0.
96
10
(4
–1
8)
8
(2
–1
6)
0.
93
(0
.9
0,
0.
95
)
0.
84
a
0
.7
4a
0
.6
6a
0.
53
a
CU
LD
14
6
0.
95
4.
5
(0
–1
0.
5)
3
(0
–1
0.
5)
0.
93
(0
.9
0,
0.
95
)
0.
84
a
0
.6
6a
0
.6
7a
0.
66
a
PS
S
16
1
0.
94
2
(0
–6
.2
5)
2
(0
–7
.5
)
0.
94
(0
.9
2,
0.
96
)
0.
79
a
0
.6
8a
0
.6
2a
0.
59
a
6.
M
ov
in
g
in
do
or
s
(0
–3
6)
AS
15
9
0.
92
4
(2
–9
)
4
(1
.5
–7
)
0.
94
(0
.9
1,
0.
96
)
0.
83
a
0
.8
3a
0
.6
6a
0.
49
a
O
A
17
0
0.
93
6
(2
–1
1)
6
(2
–1
0.
5)
0.
94
(0
.9
1,
0.
95
)
0.
83
a
0
.8
7a
0
.6
6a
0.
29
a
SL
E
15
2
0.
94
6
(2
–1
3)
5
(1
.2
5–
11
.7
5)
0.
96
(0
.9
4,
0.
97
)
0.
90
a
0
.8
9a
0
.7
3a
0.
66
a
SS
16
2
0.
93
6.
5
(2
–1
2.
5)
6
(2
–1
1)
0.
90
(0
.8
6,
0.
93
)
0.
91
a
0
.8
6a
0
.5
3a
0.
48
a
CP
18
0
0.
92
10
(6
–1
5)
10
(5
–1
6)
0.
92
(0
.8
8,
0.
94
)
0.
90
a
0
.7
9a
0
.6
3a
0.
45
a
CU
LD
14
4
0.
94
3
(1
–6
)
3
(0
–6
.5
)
0.
95
(0
.9
2,
0.
97
)
0.
85
a
0
.7
8a
0
.6
6a
0.
49
a
PS
S
15
6
0.
92
4
(1
–8
)
4
(1
–7
)
0.
96
(0
.9
5,
0.
97
)
0.
88
a
0
.8
7a
0
.7
3a
0.
45
a
7.
Cl
ea
ni
ng
th
e
ho
us
e
(0
–2
7)
AS
16
2
0.
94
0
(2
–7
)
1
(0
–4
)
0.
88
(0
.8
2,
0.
91
)
0.
80
a
0
.8
0a
0
.6
2a
0.
47
a
O
A
17
5
0.
92
5
(2
–1
0)
3
(1
–9
)
0.
92
(0
.8
8,
0.
94
)
0.
79
a
0
.6
0a
0
.5
8a
0.
42
a
(c
on
tin
ue
d)
PSYCHOMETRIC TESTING OF THE EDAQ IN MSCS 7
Ta
bl
e
5.
Co
nt
in
ue
d
Ev
al
ua
tio
n
of
D
ai
ly
Ac
tiv
ity
Q
ue
st
io
nn
ai
re
do
m
ai
n
(s
co
re
ra
ng
e)
n
Te
st
1
A
Cr
on
ba
ch
’s
a
M
ed
ia
n
(r
an
ge
)
Te
st
1
sc
or
e
M
ed
ia
n
(r
an
ge
)
Te
st
2
sc
or
e
IC
C(
2,
1)
Co
rr
el
at
io
n
w
ith
H
ea
lth
As
se
ss
m
en
t
Q
ue
st
io
n-
na
ire
20
(r
s)
Co
rr
el
at
io
n
w
ith
SF
36
v2
:P
hy
si
ca
l
Fu
nc
tio
n
(r
s)
Co
rr
el
at
io
n
w
ith
SF
36
v2
:B
od
ily
Pa
in
(r
s)
Co
rr
el
at
io
n
w
ith
H
an
d
Pa
in
(r
s)
SL
E
15
4
0.
94
5
(2
–1
2.
5)
4
(1
–1
0.
5)
0.
94
(0
.9
1,
0.
96
)
0.
88
a
0
.8
3a
0
.7
1a
0.
57
a
SS
16
2
0.
93
5
(1
–1
1.
5)
4
(2
–1
0)
0.
90
(0
.8
5,
0.
93
)
0.
88
a
0
.8
2a
0
.5
6a
0.
50
a
CP
17
7
0.
92
9
(5
–1
5)
8
(4
–1
5)
0.
89
(0
.8
4,
0.
92
)
0.
84
a
0
.7
2a
0
.5
4a
0.
50
a
CU
LD
14
3
0.
95
4
(0
–8
.5
)
3
(0
–8
)
0.
93
(0
.9
0,
0.
96
)
0.
88
a
0
.7
0a
0
.7
0a
0.
64
a
PS
S
16
2
0.
91
3
(0
–8
)
3
(0
–7
.7
5)
0.
96
(0
.9
4,
0.
97
)
0.
84
a
0
.7
9a
0
.7
3a
0.
57
a
8.
La
un
dr
y
an
d
cl
ot
he
s
ca
re
(0
–2
7)
AS
15
8
0.
95
1
(0
–3
)
0
(0
–2
)
0.
77
(0
.6
7,
0.
84
)
0.
74
a
0
.7
1a
0
.5
7a
0.
59
a
O
A
16
9
0.
91
3
(0
–7
)
2
(0
–5
)
0.
89
(0
.8
4,
0.
92
)
0.
74
a
0
.4
5a
0
.4
6a
0.
53
a
SL
E
15
4
0.
93
3
(0
–8
.2
5)
2
(0
–7
)
0.
89
(0
.8
4,
0.
92
)
0.
83
a
0
.7
5a
0
.6
7a
0.
61
a
SS
16
0
0.
90
4
(1
–8
)
4
(1
–8
)
0.
93
(0
.9
0,
0.
95
)
0.
79
a
0
.7
0a
0
.4
2a
0.
48
a
CP
18
1
0.
93
6
(1
–1
0.
5)
4
(1
–9
)
0.
93
(0
.9
0,
0.
95
)
0.
80
a
0
.6
6a
0
.6
5a
0.
53
a
CU
LD
14
6
0.
92
2
(0
–6
)
1
(0
–4
.7
5)
0.
90
(0
.8
4,
0.
93
)
0.
80
a
0
.5
6a
0
.5
5a
0.
57
a
PS
S
16
4
0.
91
1
(0
–4
)
1
(0
–4
)
0.
94
(0
.9
1,
0.
96
)
0.
76
a
0
.6
7a
0
.6
4a
0.
64
a
9.
M
ov
in
g
an
d
tr
an
sf
er
s
(0
–1
8)
AS
16
1
0.
90
4
(2
–6
)
3
(1
–5
)
0.
91
(0
.8
6,
0.
93
)
0.
80
a
0
.7
7a
0
.7
4a
0.
40
a
O
A
17
7
0.
88
4
(1
–7
)
2
(0
–6
)
0.
89
(0
.8
5,
0.
92
)
0.
78
a
0
.7
7a
0
.5
8a
0.
28
a
SL
E
16
1
0.
90
3
(1
–6
)
2
(0
–5
.7
5)
0.
90
(0
.8
6,
0.
93
)
0.
85
a
0
.7
3a
0
.7
3a
0.
67
a
SS
16
9
0.
88
3
(0
–5
)
2
(0
–5
)
0.
91
(0
.8
8,
0.
94
)
0.
79
a
0
.7
2a
0
.5
5a
0.
41
a
CP
19
1
0.
87
6
(4
–9
)
5
(3
–8
)
0.
90
(0
.8
6,
0.
93
)
0.
84
a
0
.7
2a
0
.6
3a
0.
46
a
CU
LD
15
2
0.
88
2
(0
–4
.2
5)
1
(0
–4
)
0.
92
(0
.8
9,
0.
95
)
0.
73
a
0
.6
6a
0
.6
8a
0.
44
a
PS
S
16
5
0.
87
2
(0
–5
)
2
(0
–4
)
0.
95
(0
.9
4,
0.
97
)
0.
81
a
0
.7
6a
0
.7
3a
0.
49
a
10
.C
om
m
un
ic
at
io
n
(0
–1
8)
AS
16
4
0.
89
0
(0
–1
)
0
(0
–1
)
0.
90
(0
.8
5,
0.
93
)
0.
47
a
0
.4
5a
0
.3
8a
0.
54
a
O
A
17
8
0.
90
1
(0
–3
)
0
(0
–2
)
0.
88
(0
.8
3,
0.
91
)
0.
50
a
0
.1
8b
0
.4
0a
0.
55
a
SL
E
16
3
0.
85
1
(0
–3
)
0
(0
–2
)
0.
89
(0
.8
4,
0.
92
)
0.
65
a
0
.5
4a
0
.5
2a
0.
56
a
SS
16
6
0.
83
1
(0
–4
)
1
(0
–4
)
0.
91
(0
.8
8,
0.
94
)
0.
69
a
0
.5
1a
0
.4
7a
0.
48
a
CP
19
0
0.
90
2
(0
–5
)
1
(0
–4
)
0.
91
(0
.8
7,
0.
94
)
0.
65
a
0
.5
0a
0
.4
7a
0.
55
a
CU
LD
14
9
0.
87
2
(0
–4
)
1
(0
–3
)
0.
91
(0
.8
6,
0.
94
)
0.
51
a
0
.3
0a
0
.3
8a
0.
49
a
PS
S
16
9
0.
89
0
(0
–1
)
0
(0
–1
.2
5)
0.
89
(0
.8
5,
0.
92
)
0.
56
a
0
.5
0a
0
.5
5a
0.
58
a
11
.M
ov
in
g
ou
td
oo
rs
an
d
sh
op
pi
ng
(0
–3
9)
AS
15
7
0.
94
4
(0
–1
0)
2
(0
–8
)
0.
94
(0
.9
1,
0.
96
)
0.
83
a
0
.9
0a
0
.7
1a
0.
54
a
O
A
16
2
0.
91
5
(3
–1
3)
5
(2
–1
0)
0.
95
(0
.9
2,
0.
97
)
0.
86
a
0
.8
5a
0
.6
2a
0.
35
a
SL
E
15
3
0.
93
7
(2
–1
5)
5
(1
–1
2)
0.
96
(0
.9
3,
0.
97
)
0.
92
a
0
.8
9a
0
.7
5a
0.
67
a
SS
16
2
0.
92
7
(2
–1
4)
6
(2
–1
3)
0.
97
(0
.9
5,
0.
98
)
0.
90
a
0
.9
1a
0
.5
6a
0.
49
a
CP
17
9
0.
91
11
(6
–1
9)
10
(5
.7
5–
17
.2
5)
0.
89
(0
.8
2,
0.
93
)
0.
85
a
0
.8
0a
0
.6
7a
0.
51
a
CU
LD
14
7
0.
94
4
(1
–8
)
3
(0
–6
)
0.
87
(0
.8
1,
0.
91
)
0.
84
a
0
.7
3a
0
.6
9a
0.
58
a
PS
S
15
9
0.
92
4
(1
–9
)
4
(0
–9
)
0.
89
(0
.8
2,
0.
93
)
0.
88
a
0
.9
0a
0
.7
5a
0.
54
a
12
.G
ar
de
ni
ng
/h
ou
se
m
ai
nt
en
an
ce
(0
–2
1)
AS
15
5
0.
93
3
(1
–8
)
3
(1
–6
)
0.
85
(0
.7
8,
0.
90
)
0.
80
a
0
.7
6a
0
.5
6a
0.
52
a
O
A
16
9
0.
92
5
(2
–1
2)
5
(2
–1
0.
75
)
0.
84
(0
.7
8,
0.
89
)
0.
66
a
0
.6
4a
0
.5
0a
0.
33
a
SL
E
14
5
0.
94
6
(1
–1
4.
5)
4
(1
–1
3)
0.
78
(0
.6
6,
0.
85
)
0.
76
a
0
.6
9a
0
.6
6a
0.
55
a
SS
15
0
0.
92
6
(2
–1
4)
5
(1
–1
2.
75
)
0.
87
(0
.8
2,
0.
91
)
0.
73
a
0
.7
2a
0
.4
5a
0.
36
a
CP
17
3
0.
91
10
(4
–1
7.
5)
7.
5
(2
–1
7)
0.
88
(0
.8
3,
0.
92
)
0.
64
a
0
.6
2a
0
.4
8a
0.
39
a
CU
LD
13
3
0.
95
3
(0
–8
.5
)
2
(0
–8
)
0.
86
(0
.7
9,
0.
91
)
0.
79
a
0
.6
5a
0
.5
9a
0.
55
a
PS
S
15
0
0.
92
2
(0
–8
)
3
(0
–7
)
0.
79
(0
.6
9,
0.
85
)
0.
60
a
0
.5
9a
0
.4
9a
0.
38
a
a p
¼
<
0.
00
1.
b
p
<
0.
05
.
a:
Cr
on
ba
ch
’s
al
ph
a;
r s
:S
pe
ar
m
an
’s
co
rr
el
at
io
n
co
ef
fic
ie
nt
.
AS
:
an
ky
lo
si
ng
sp
on
dy
lit
is
;
O
A:
os
te
oa
rt
hr
iti
s;
SL
E:
sy
st
em
ic
lu
pu
s
er
yt
he
m
at
os
us
;
SS
:
sy
st
em
ic
sc
le
ro
si
s;
CP
:
ch
ro
ni
c
pa
in
co
nd
iti
on
s;
CU
LD
:
ch
ro
ni
c
ha
nd
/u
pp
er
lim
b
di
so
rd
er
s;
PS
S:
pr
im
ar
y
Sj
€ og
re
n’
s
sy
nd
ro
m
e.
N
eg
at
iv
e
co
rr
el
at
io
ns
oc
cu
r
w
ith
SF
36
v2
sc
or
es
as
hi
gh
er
sc
or
es
re
pr
es
en
t
be
tt
er
fu
nc
tio
n
in
th
e
SF
36
v2
.
8 A. HAMMOND ET AL.
the commonest conditions referred to rheumatology and muscu-
loskeletal rehabilitation services. This overcomes therapists’ per-
ceived limitations of physical function measures widely used in
Rheumatology (such as the Health Assessment Questionnaire), i.e.,
as being too short to aid treatment planning, insufficient to show
change following rehabilitation and inappropriately worsening
scores if assistive devices are used [5,6]. It could also be particu-
larly helpful for junior staff to use, to aid their assessment and
treatment planning, who may be less aware of these client
groups’ potential problems.
The Evaluation of Daily Activity Questionnaire differs from other
measures of activity ability, used in musculoskeletal conditions, in
that it distinguishes between intrinsic disability (i.e., without ergo-
nomic and environmental modifications, i.e., Part 2, Section A) and
actual disability (i.e., with such modifications, i.e., Part 2, Section B).
Furthermore, the Evaluation of Daily Activity Questionnaire aims to
engage people in the process of identifying their own problems
(Part 2, Section A), reflecting on effectiveness of their existing solu-
tions (Part 2, Section B) and empowering them to problem solve,
with the aid of a therapist, when necessary. As one participant in
the development phase stated: “At first you think a lot doesn’t
apply to me…but it does when you think about it… it helped me
a lot to see there could be solutions… the questionnaire makes
you think about your arthritis” [15]. The content was generated by
people with rheumatoid arthritis and musculoskeletal conditions
[6,7,15], as opposed to other physical function assessments com-
monly used in musculoskeletal research and practice, in which
items were generated by health professionals [3,4]. This contrib-
uted to the Evaluation of Daily Activity Questionnaire’s high levels
of acceptability by respondents, despite its length.
There is increasing pressure on rehabilitation services to make
appointments more efficient. This patient reported outcome meas-
ure, completed at home in advance of appointments, can speed up
assessment (as it reduces the timed needed to interview clients),
increasing the time available to collaboratively problem-solve, dis-
cuss and try out treatment options and thus potentially improve
the effectiveness of and clients’ satisfaction with therapy services.
The Evaluation of Daily Activity Questionnaire meets most of
the recommendations for patient reported outcome measures of
the United States Food and Drug Administration [48] and the
COnsensus-based Standards for the selection of health
Measurement INstruments (COSMIN) checklist [49], apart from
responsiveness which requires evaluation within a clinical trial or
clinical setting. Consequently, the Evaluation of Daily Activity
Questionnaire can be used in research and audit, as well as clin-
ical practice. In future, domains could be used as item banks to
support computer adaptive testing.
The results show that the 12 domain, two component structure
(Self-Care and Mobility), developed for people with rheumatoid
arthritis [11], also fits for these other seven musculoskeletal condi-
tions. The results were also similar to the findings in the rheuma-
toid arthritis study [11]. There were minor differences between
genders (Differential Item Functioning) but this was probably
affected by the nature of items in some domains and smaller
numbers of male participants for some musculoskeletal conditions.
For example, men may be more likely to climb ladders (in the
House and Garden Maintenance domain). As this structure is
robust and satisfies Rasch model expectations, raw scores for
items in each domain and component, in each musculoskeletal
condition, can be summed to create both total domain and the
two component scores. Consequently, individual domains or com-
ponents can be used in practice or research to meet the needs of
the client or research being conducted. Rasch transformation
tables for each condition can be used if parametric analyses are
required which convert the ordinal total score to an interval scale.
These can be found in the Evaluation of Daily Activity
Questionnaire manual [10]. As we identified Differential Item
Functioning by condition, this indicates that the raw Evaluation of
Daily Activity Questionnaire scores are not directly comparable
between different conditions. However, if comparison between
conditions is required, cross-conditional Rasch transformation
tables are available for this purpose [10].
The limitations of the Evaluation of Daily Activity Questionnaire
for these musculoskeletal conditions are that floor effects were
evident across most domains and conditions. The highest floor
effects were observed in the ankylosing spondylitis and Primary
Sj€ogrens Syndrome groups in the Eating, Personal Care, Cooking,
Laundry and Communication domains, as participants had few
limitations in these activities. Most ankylosing spondylitis partici-
pants were men and we identified during the content validity
phase that many men did not have limitations in these domains
as their hands were unaffected. However, women with ankylosing
spondylitis did experience hand problems and found these
domains problematic [15]. Thus the items were retained. For the
Primary Sj€ogrens Syndrome group, activity limitations are more
often influenced by fatigue than hand function limitations.
Furthermore, while test–retest reliability results were moderate to
excellent overall, the retest period was longer than planned.
Although we analysed data only for those perceiving themselves
“about the same” as when completing Test 1, participants’ status
may not have been stable. In particular, this may account for why
Part 1 scales had moderate reliability.
Over a third of respondents were recruited from patient organ-
isations, which potentially could affect the representativeness of
the findings, as such groups are often thought to be better edu-
cated than clinic populations. This was the case in our samples in
three condition groups. However, the key demographic and condi-
tion duration factors were very similar in people recruited from
the different sources. We consider our wide recruitment strategies
to be a strength rather than a weakness as it meant we were able
to recruit a broader swathe of the population, than just those
who attended clinic during the recruitment period.
Conclusion
The Evaluation of Daily Activity Questionnaire is a psychometric-
ally robust, comprehensive measure of activity limitations which
can now be used with a wide range of musculoskeletal conditions.
Either the whole Evaluation of Daily Activity Questionnaire, either
component or the individual domains can be used in clinical prac-
tice to identify clients’ daily activity problems and help find solu-
tions, or as an outcome measure in research and audit. Further
work is needed to assess the responsiveness of the Evaluation of
Daily Activity Questionnaire and its implementation into clinical
practice. The Evaluation of Daily Activity Questionnaire also has
the potential to be relevant for other client groups (e.g., other
musculoskeletal conditions, neurological conditions, such as mul-
tiple sclerosis), although further research would be needed to
establish content validity in these.
The Evaluation of Daily Activity Questionnaire, a user manual
and support materials are available for use by patients, clinicians
and researchers [9,10,50].
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